Stockscreener 앱 받기
3.31
2.07%
-0.07
시간 외 거래:
3.30
-0.01
-0.30%
전일 마감가:
$3.38
열려 있는:
$3.37
하루 거래량:
23,246
Relative Volume:
0.81
시가총액:
$75.03M
수익:
$35.16M
순이익/손실:
$-11.44M
주가수익비율:
-5.5528
EPS:
-0.5961
순현금흐름:
$-15.44M
1주 성능:
+9.60%
1개월 성능:
-19.27%
6개월 성능:
-39.82%
1년 성능:
-51.61%
1일 변동 폭
$3.30
$3.55
1주일 범위
$3.03
$3.55
52주 변동 폭
$3.02
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Compare BHST vs JBS, KHC, GIS, HRL, MKC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
3.31 | 76.62M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
12.30 | 40.09B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
23.80 | 28.45B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
34.40 | 18.29B | 18.37B | 2.22B | 1.65B | 4.0676 |
HRL
Hormel Foods Corp
|
24.65 | 13.53B | 12.22B | 466.64M | 692.94M | 0.8477 |
MKC
Mccormick Co Inc
|
47.19 | 12.87B | 7.11B | 1.65B | 680.40M | 6.1005 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Roth Capital | Buy |
| 2025-05-05 | 개시 | Craig Hallum | Buy |
| 2024-12-18 | 개시 | Maxim Group | Buy |
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
BHST PE Ratio & Valuation, Is BHST Overvalued - Intellectia AI
BioHarvest Sciences Q1 2025 Earnings: EPS Misses Estimates While Stock Sees Positive ReactionSegment Revenue Breakdown - newsline.com
BioHarvest Sciences Inc. (BHST) Advances 2.75% as Shares Hold Above Key SupportLong Setup Ideas - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: Higher Losses Weigh on Operational ProgressEarnings Preview - newsline.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
BioHarvest Sciences (BHST) Gains Nearly 1% as Shares Test Key ResistanceUp Down Ratio - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesPerformance Review - newsline.com
BHST Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Revision Upgrade - newsline.com
BioHarvest (BHST) Q4 2025 Earnings Transcript - AOL.com
BioHarvest Sciences (BHST) Retreats to Key Support Level After Modest DeclinePrice Action Signals - newsline.com
BioHarvest Sciences Files Form 6-K With Meeting Materials for Upcoming Shareholder Vote - TipRanks
BioHarvest Sciences (BHST) schedules 2026 AGM to elect board and ratify auditor - Stock Titan
BioHarvest Sciences Inc. (BHST) Edges Higher as Price Approaches Resistance After Support TestHigh Dividend Factor - The Legal Advocate
Tate & Lyle expands BioHarvest partnership for next-gen sweetener innovation - FoodTechBiz
BioHarvest Sciences Inc. (BHST) Edges Higher as Trading Volume Picks UpPercent Above MA - The Legal Advocate
BioHarvest Sciences Inc. (BHST) Finds Support, Bounces to $3.86Double EMA - The Legal Advocate
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation - TMX Newsfile
BioHarvest Sciences (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Navigates Early-Stage CommercializationRevenue Inflection Point - The Legal Advocate
Bioharvest Sciences Signals Progress Amid Near-Term Losses - TipRanks
BioHarvest Sciences and Tate & Lyle expand sweetener development program - Yahoo! Finance Canada
Tate & Lyle expands collaboration with BioHarvest to accelerate next-generation sweetener innovation - Asia Food Journal
BioHarvest (BHST) Q1 2026 Earnings Transcript - AOL.com
BioHarvest expands Tate & Lyle sweetener development deal By Investing.com - Investing.com Australia
Tate & Lyle expands plant-based sweetener innovation partnership with BioHarvest Sciences - New Food
BioHarvest expands Tate & Lyle sweetener development deal - Investing.com UK
BioHarvest Sciences Q1 earnings call highlights - MSN
BioHarvest outlines 2026 revenue of $38M-$42M in D2C and $12M-$14M in CDMO activity while targeting 2H 2027 fragrance production - MSN
H.C. Wainwright Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $14 - Moomoo
BioHarvest Sciences Inc. Common Stock Q1 2026 Earnings Call Summary - Yahoo Finance
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: - GuruFocus
BioHarvest Sciences (NASDAQ:BHST) Announces Quarterly Earnings Results - MarketBeat
BioHarvest Sciences Inc. (BHST) reports Q4 loss, lags revenue estimates - MSN
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
BioHarvest Sciences Posts Q1 2026 Growth and Advances Botanical Synthesis Deals - TipRanks
BioHarvest Sciences: Q1 revenue up 8% YoY, CDMO revenue up 135%, net loss at $2.6M, gross margin at 59% - TradingView
BioHarvest Sciences (NASDAQ: BHST) posts Q1 2026 growth with $8.5M revenue - Stock Titan
Small cap wrap: VivoPower, BioHarvest Sciences, Phunware, Tiziana Life Sciences… - Proactive financial news
BioHarvest Sciences Files Q1 2026 Financials on Form 6-K - TipRanks
BioHarvest Sciences Q1 2026 Earnings Call Transcript - MarketBeat
BioHarvest Sciences (NASDAQ: BHST) grows Q1 2026 revenue while warning on going concern - Stock Titan
BioHarvest Sciences Names New Business Development Chief to Drive CDMO Growth - TipRanks
Bioharvest Sciences Inc (BHST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.17%
1.67%
자본화:
|
볼륨(24시간):